Medicure Inc. (TSXV: MPH)
MPH trades on the TSX Venture Exchange in Life Sciences, headquartered in Manitoba. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for MPH.V, last bar 2026-10-14, computed by Sophia Capital.
Profile
| Field | Value |
|---|---|
| Ticker | MPH on the TSX Venture Exchange |
| Yahoo symbol | MPH.V |
| Sector | Life Sciences |
| Headquarters | Manitoba |
| Listed | 2010-03-29 |
| Listing type | TSX Comedown |
| Shares outstanding | 10,436,313 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001133519 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | +15.4% |
| 1 week | +45.7% |
| 1 month | +70.8% |
| 3 months | +299.1% |
| 6 months | +216.3% |
| Year to date | +274.6% |
| 1 year | +322.8% |
| From 52-week high | 0.0% |
| 52-week range | C$0.9000 to C$4.27 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
46 documents in 6 types. Each title links to the document at its source.
Interim financial statements (6)
| Document | Type | Filed |
|---|---|---|
| FINANCIAL STATEMENTS | Interim financial statements (6-K) | 2026-08-19 |
| FINANCIAL STATEMENTS Period 2026-03-31 | Interim financial statements (6-K) | 2026-05-21 |
| FINANCIAL STATEMENTS Period 2025-09-30 | Interim financial statements (6-K) | 2025-11-19 |
| FINANCIAL STATEMENTS Period 2025-06-30 | Interim financial statements (6-K) | 2025-08-21 |
MD&A (3)
| Document | Type | Filed |
|---|---|---|
| Q2 MD&A | MD&A (interim) (6-K) | 2026-08-19 |
| MANAGEMENT'S DISCUSSION AND ANALYSIS Period 2025-09-30 | MD&A (interim) (6-K) | 2025-11-19 |
| Q3 MD&A | MD&A (interim) (6-K) | 2024-11-26 |
News release (17)
| Document | Type | Filed |
|---|---|---|
| PRESS RELEASE | News release (6-K) | 2026-08-19 |
| PRESS RELEASE | News release (6-K) | 2026-05-21 |
| PRESS RELEASE | News release (6-K) | 2026-05-21 |
| PRESS RELEASE | News release (6-K) | 2026-04-24 |
Annual report (2)
| Document | Type | Filed |
|---|---|---|
| FORM 20-F Period 2025-12-31 | Annual report (20-F) (20-F) | 2026-04-24 |
| FORM 20-F Period 2024-12-31 | Annual report (20-F) (20-F) | 2025-04-25 |
Certification (10)
| Document | Type | Filed |
|---|---|---|
| CEO Certification | Certification (52-109) (6-K) | 2026-08-19 |
| CFO Certification | Certification (52-109) (6-K) | 2026-08-19 |
| CERTIFICATION OF CEO Period 2024-12-31 | Certification (52-109) (20-F) | 2025-04-25 |
| CERTIFICATION OF CFO Period 2024-12-31 | Certification (52-109) (20-F) | 2025-04-25 |
Other (8)
| Document | Type | Filed |
|---|---|---|
| CONSENT Period 2025-12-31 | Consent (20-F) | 2026-04-24 |
| CONSENTS Period 2024-12-31 | Consent (20-F) | 2025-04-25 |
| INSIDER TRADING POLICY Period 2025-12-31 | Material contract / governance (20-F) | 2026-04-24 |
| CLAWBACK POLICY Period 2025-12-31 | Material contract / governance (20-F) | 2026-04-24 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| LABS | MediPharm Labs Corp. | TSX | C$29.9M | -13.3% | -18.8% |
| RVX | Resverlogix Corp. | TSX | C$31.0M | -5.6% | -22.7% |
| ROMJ | Rubicon Organics Inc. | TSXV | C$33.0M | -6.4% | -21.4% |
| NPTH | NeuPath Health Inc. | TSXV | C$34.2M | +13.7% | +56.8% |
| TTI | Thiogenesis Therapeutics, Corp. | TSXV | C$34.3M | 0.0% | -28.6% |
The app has the price chart, every filing, private raises and the full peer set for MPH.
Open in the app